Background and Aims
A novel high dose, short duration walking training program was delivered three hours daily over three weeks to community-dwelling stroke survivors. The aims of this study were to (1) to explore the acceptability, adherence and exercise dose during the program and (2) examine physiotherapists’ perceptions and delivery of the program.
Methods
This study involved intervention participants from a Phase II trial (HiWalk, n=23) and all trial physiotherapists (n=6). Quantitative measures including participant adherence (attendance and exercise count) were summarised descriptively. Qualitative data from stroke participant and therapist semi structured interviews were analysed thematically to explore acceptability and the facilitators and barriers to delivery.
Results
Stroke participants had a mean age of 58 years (SD 15), were 3.1 years (SD 2.4) post stroke and had a fast-walking speed of 0.9 m/s (SD 0.4). Stroke participants attended 91% (SD 13) of program sessions, averaged 567 exercise repetitions per hour (SD 171) and reported the opportunity to attend, alongside being motivated and having support networks facilitated adherence. Physiotherapists were observed to deliver the program as per the protocol and reported training, resources and team collaboration facilitated delivery.
Conclusion
High dose, short duration motor training was highly acceptable to stroke survivors who demonstrated strong adherence. Physiotherapists reported training, mentorship and structured resources to prescribe and monitor high dose motor training supported delivery.